Last updated: June 05, 2014
The Cancer Genome Atlas 3rd Annual Scientific Symposium:
The Cancer Genome Atlas 3rd Annual Scientific Symposium:
On May 12-13, 2014, The Cancer Genome Atlas (TCGA) held its third annual scientific symposium at Natcher Conference Center in Bethesda, Md. Through collaborative workshops, poster sessions and plenary presentations, TCGA investigators from around the world shared their novel biological discoveries, analytical methods and translational approaches using TCGA data.
View symposium videos and slides from: 
May 12 | May 13
Monday, May 12, 2014
| 1 | Opening
| Matthew Meyerson, M.D., Ph.D. Dana-Farber Cancer Institute Marco Marra, Ph.D. British Columbia Cancer Agency |
| 2 | Keynote Address
| Robert Grossman, Ph.D. University of Chicago |
| 3 | Session I Introduction
| Han Liang, Ph.D. University of Texas MD Anderson Cancer Center |
| 4 | Comprehensive and Integrative Genomic Characterization of Diffuse Lower Grade Gliomas
| Daniel Brat, Ph.D. Emory University School of Medicine |
| 5 | Using TCGA Data to Inform on Precision Medicine in Late Stage Cancer Settings
| Andrew J. Mungall, Ph.D. British Columbia Cancer Agency |
| 6 | The ICGC-TCGA DREAM Somatic Mutation Calling Challenge: Initial Results
| Paul Boutros, Ph.D. Ontario Institute for Cancer Research |
| 7 | Lessons Learned from the Genomic Characterization of Patient-Matched Frozen and Formalin Fixed, Paraffin-Embedded Tissues: Progress Update
| Erik Zmuda, Ph.D. Nationwide Children's Hospital |
| 8 | Domain-specific PIK3CA mutations affect different pathway activities across >3000 TCGA Pan-Cancer-12 tumors
| Christopher Benz, M.D. Buck Institute for Research on Aging |
| 9 | Comprehensive Molecular Profiling of Adrenocortical Carcinoma
| Siyuan Zheng, Ph.D. University of Texas M.D. Anderson Cancer Center |
| 10 | Session II Introduction
| Josh Stuart, Ph.D. University of California, Santa Cruz |
| 11 | Comprehensive Molecular Characterization of Chromophobe Renal Cell Carcinoma
| Chad Creighton, Ph.D. Baylor College of Medicine |
| 12 | Prediction of Individualized Therapeutic Vulnerabilities In Cancer from Genomic Profiles
| Bulent Arman Aksoy Memorial Sloan-Kettering Cancer Center |
| 13 | Recurrent Epistates Define Tumor Methylome Differences
| Huy Q. Dinh, Ph.D. University of Southern California |
| 14 | What do we learn from Pan-Cancer Subtyping?
| Josh Stuart, Ph.D. University of California, Santa Cruz |
| 15 | Profiling Long Intergenic Non-Coding RNA Interactions In The Cancer Genome
| Samir B. Amin, M.D. University of Texas MD Anderson Cancer Center |
| 16 | Multi-Omics Classification of Head and Neck Cancer Ties TP53 Mutation To 3p Loss
| Andrew M. Gross University of California, San Diego |
Tuesday, May 13, 2014
| 17 | Session III Introduction
| Peter Laird, Ph.D. University of Southern California |
| 18 | Integrated Genomic Characterization of Papillary Thyroid Carcinoma
| Thomas J. Giordano M.D., Ph.D. University of Michigan |
| 19 | Somatic Alterations In Clinically Relevant Cancer Genes Among 12 TCGA Tumor Types
| Ali Amin-Mansour Broad Institute |
| 20 | Inferring Intra-Tumor Heterogeneity from Whole-Genome/Exome Sequencing Data
| Layla Oesper, M.S. Brown University |
| 21 | Genomic Characterization of Invasive Lobular Breast Carcinoma
| Michael L. Gatza, Ph.D. The University of North Carolina at Chapel Hill |
| 22 | LineUp: Identifying Deleterious Mutations Using Protein Domain Alignment
| Brady Bernard, Ph.D. Institute for Systems Biology |
| 23 | Integrative Analysis of TCGA Data Reveals Wilms' Tumor 1 Mutation is a Driver of DNA Methylation in Acute Myeloid Leukemia
| Subarna Sinha, Ph.D. Stanford University |
| 24 | The Pan-Cancer Proteomic Landscape of The Cancer Genome Atlas Projects
| Rehan Akbani, Ph.D. The University of Texas MD Anderson Cancer Center |
| 25 | Comprehensive Genomic Characterization of Cutaneous Melanoma
| Ian R. Watson, Ph.D. The University of Texas MD Anderson Cancer Center |
| 26 | Data Mining TCGA Breast and Ovarian Exomes for Novel Susceptibility Markers
| John Martignetti, M.D., Ph.D. Icahn School of Medicine at Mount Sinai |
| 27 | Discovery and Functional Characterization of Recurrent Gene Fusions from 4,932 Primary Tumor Transcriptomes Across 19 Human Cancers
| Chai Bandlamudi, M.S. The University of Chicago |
| 28 | Widespread Genetic Epistasis Among Cancer Genes
| Audrey Q. Fu, Ph.D. The University of Chicago |
| 29 | Understanding the Evolution of Melanoma Epigenome
| Kadir C. Akdemir, Ph.D. The University of Texas MD Anderson Cancer Center |
| 30 | Comprehensive Molecular Characterization of Gastric Adenocarcinoma
| Adam Bass, M.D. Dana-Farber Cancer Institute |
| 31 | Integrated Analysis of Metastatic Disease in Clear Cell Renal Cell Carcinoma: A Collaborative TCGA Analysis
| A. Ari Hakimi, M.D. Memorial Sloan-Kettering Cancer Center |
| 32 | Multi-Center Mutation Calling in TCGA
| David A. Wheeler, Ph.D. Baylor College of Medicine |
| 33 | Extensive Trans And cis-QTLs Revealed By Large-Scale Cancer Genome Analysis
| Kjong-Van Lehmann, Ph.D. Memorial Sloan-Kettering Cancer Center |
| 34 | Pan-Cancer Analysis of APOBEC Mutagenesis
| Dmitry A. Gordenin, Ph.D. National Institute of Environmental Health Sciences, NIH |
| 35 | Integration of Multiple Data Types for Genomic Characterization of Virus-Associated Tumors
| Matthew A. Wyczalkowski, Ph.D. Washington University School of Medicine |
| 36 | Closing Remarks
| Matthew Meyerson, M.D., Ph.D. Dana-Farber Cancer Institute |